# UCDCCC NCTN UG1 PROGRAM

> **NIH NIH UG1** · UNIVERSITY OF CALIFORNIA AT DAVIS · 2023 · $494,871

## Abstract

PROJECT SUMMARY/ABSTRACT
As the only NCI-designated cancer center for inland Northern California's approximately 6 million people, the
UC Davis Comprehensive Cancer Center (UCDCCC) provides both primary cancer care to a large and
growing population, and serves as the tertiary referral center for specialty cancer care for the region. For this
application as a NCTN Network Lead Academic Participating Site, led by Drs. David R Gandara, MD, and
Richard K Valicenti, MD, UCDCCC will leverage an already established multidisciplinary team of cancer
investigators from medical oncology, radiation oncology, surgical specialties, molecular biology/genomics,
pathology, radiology, biostatistics, nursing, and clinical research support to provide clinical trials expertise,
scientific and administrative leadership and accrual in NCTN studies across a broad range of tumor types and
throughout the NCTN group network. UCDCCC and its faculty have a long-standing and proven track record of
impactful contribution to NCI-sponsored clinical trials activities, as well as to NCI-related steering committees
and initiatives. This UG1 effort is anticipated to increase both the scope and reach of participation, including
integrating additional researchers and providing career development opportunities for new faculty and junior
investigators. With an already strong track record in translational and clinical research leadership for NCTN,
UCDCCC is poised to exploit unique institutional strengths in serving as a laboratory resource for clinical trials
and contributing to hypothesis-driven clinical research.
Based on over two decades of already serving as the clinical trials “hub” for accrual to NCI-sponsored studies
throughout North-Central California, this NCTN UG1 initiative creates a additional opportunities for UCDCCC to
both increase main site accrual and to extend access to NCTN trials into the community through the UCDCCC
Cancer Care Network and affiliate site, which includes substantial underserved, rural and minority patient
populations. In summary, UCDCCC represents an interdisciplinary organizational and leadership structure
linked to a clinical trials program that will be impactful and ensure robust accrual to NCTN trials.

## Key facts

- **NIH application ID:** 10584617
- **Project number:** 5UG1CA233340-05
- **Recipient organization:** UNIVERSITY OF CALIFORNIA AT DAVIS
- **Principal Investigator:** DAVID R GANDARA
- **Activity code:** UG1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2023
- **Award amount:** $494,871
- **Award type:** 5
- **Project period:** 2019-03-06 → 2025-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10584617

## Citation

> US National Institutes of Health, RePORTER application 10584617, UCDCCC NCTN UG1 PROGRAM (5UG1CA233340-05). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10584617. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*